{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:31:41Z","timestamp":1768710701299,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1136\/ijgc-2019-000586","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T06:19:07Z","timestamp":1564553947000},"page":"1298-1303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of  F-fluoro-2-deoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up"],"prefix":"10.1016","volume":"29","author":[{"given":"Carlotta","family":"Dolci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ceppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Crivellaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lamanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Adorni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Maria","family":"Bonazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Fruscio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000586_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ctrv.2008.02.002","article-title":"Germ cell tumors of the ovary","volume":"34","author":"Pectasides","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1136\/ijgc-2019-000586_bb0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","article-title":"Incidence and survival rates for female malignant germ cell tumors","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000586_bb0020","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ygyno.2004.11.027","article-title":"Outcome and prognostic factors in ovarian germ cell malignancies","volume":"96","author":"Lai","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000586_bb0025","first-page":"128","article-title":"Malignant germ cell tumors of the ovary","volume":"95","author":"Tewari","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000586_bb0030","first-page":"815","article-title":"FDG PET for detection and therapy control of metastatic germ cell tumor","volume":"39","author":"Cremerius","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1136\/ijgc-2019-000586_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00345-004-0403-2","article-title":"The role of positron emission tomography in germ cell cancer","volume":"22","author":"De Santis","year":"2004","journal-title":"World J Urol"},{"key":"10.1136\/ijgc-2019-000586_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1445-5994.2003.00456.x","article-title":"Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up","volume":"33","author":"Karapetis","year":"2003","journal-title":"Intern Med J"},{"key":"10.1136\/ijgc-2019-000586_bb0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s002590050547","article-title":"Fluorodeoxyglucose PET in the initial staging of germ cell tumours","volume":"27","author":"Hain","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1136\/ijgc-2019-000586_bb0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1054\/bjoc.2000.1389","article-title":"Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse","volume":"83","author":"Hain","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2019-000586_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1464-410X.2002.02641.x","article-title":"The role of 18fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours","volume":"89","author":"Spermon","year":"2002","journal-title":"BJU Int"},{"key":"10.1136\/ijgc-2019-000586_bb0060","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(197612)38:6<2404::AID-CNCR2820380629>3.0.CO;2-3","article-title":"Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases","volume":"38","author":"Kurman","year":"1976","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000586_bb0065","first-page":"194","article-title":"Endodermal sinus tumor of the ovary: the M.D. Anderson experience","volume":"61","author":"Gershenson","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000586_bb0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0142(19910101)67:1<184::AID-CNCR2820670131>3.0.CO;2-C","article-title":"Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases","volume":"67","author":"Kawai","year":"1991","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000586_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12149-010-0449-8","article-title":"Present and future of FDG-PET\/CT in ovarian cancer","volume":"25","author":"Kitajima","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1136\/ijgc-2019-000586_bb0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.1994.12.4.701","article-title":"Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group","volume":"12","author":"Williams","year":"1994","journal-title":"JCO"},{"key":"10.1136\/ijgc-2019-000586_bb0085","first-page":"624","article-title":"Immature teratoma of the ovary","volume":"68","author":"Gershenson","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000586_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R","article-title":"Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy","volume":"62","author":"Culine","year":"1996","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2019-000586_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000337056","article-title":"Can we rely on PET in the follow-up of advanced seminoma patients?","volume":"88","author":"Siekiera","year":"2012","journal-title":"Urol Int"},{"key":"10.1136\/ijgc-2019-000586_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000048442","article-title":"Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors","volume":"68","author":"Tsatalpas","year":"2002","journal-title":"Urol Int"},{"key":"10.1136\/ijgc-2019-000586_bb0105","first-page":"1653","article-title":"Cancer or inflammation? A Holy Grail for nuclear medicine","volume":"35","author":"Larson","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1136\/ijgc-2019-000586_bb0110","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00259-008-0776-3","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET\/non-contrast-enhanced CT and enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1136\/ijgc-2019-000586_bb0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1148\/rg.312105713","article-title":"Role of FDG PET\/CT in staging of recurrent ovarian cancer","volume":"31","author":"Son","year":"2011","journal-title":"Radiographics"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:37:32Z","timestamp":1753101452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1048891X24002809"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000586","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 18F-fluoro-2-deoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}